A detailed history of Clearstead Trust, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clearstead Trust, LLC holds 1,179 shares of NVO stock, worth $124,926. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,179
Previous 1,179 -0.0%
Holding current value
$124,926
Previous $168,000 16.67%
% of portfolio
0.04%
Previous 0.05%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $10,721 - $14,271
105 Added 9.78%
1,179 $151,000
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $1,404 - $1,687
16 Added 1.51%
1,074 $111,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $54,927 - $120,522
604 Added 133.04%
1,058 $96,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $9,403 - $11,366
-101 Reduced 18.2%
454 $50,000
Q3 2021

Nov 02, 2021

BUY
$84.42 - $106.62 $46,853 - $59,174
555 New
555 $53,000
Q3 2017

Nov 17, 2017

SELL
$41.15 - $49.22 $61,725 - $73,830
-1,500 Closed
0 $0
Q2 2017

Aug 21, 2017

BUY
N/A
1,500
1,500 $64,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.